Clinical Trials Sponsored by Eastern Hepatobiliary Surgery Hospital

Total 111 results

Eastern Hepatobiliary Surgery Hospital

Active, not recruiting

Cadonilimab Plus TACE in Patients With Intermediate-stage Unresectable Hepatocellular Carcinoma

Hepatocellular Carcinoma

China
Eastern Hepatobiliary Surgery Hospital

Completed

Vascular Invasion Signatures in cfDNA Support Re-staging of Liver Cancer

Carcinoma, Hepatocellular | Liver Cancer | Hepatocellular Cancer

China
Eastern Hepatobiliary Surgery Hospital

Completed

Adjuvant Radiotherapy for Resected Hepatocellular Carcinoma With MVI

Hepatocellular Carcinoma

China
Eastern Hepatobiliary Surgery Hospital

Completed

Total Hemihepatic Vascular Exclusion in Hepatectomy in Hepatocellular Carcinoma Treatment

Hepatocellular Carcinoma

China
Eastern Hepatobiliary Surgery Hospital

Completed

A Trial of Adjuvant Transarterial Chemoembolization (TACE) for Preventing Tumor Recurrence After Liver Resection

Hepatocellular Carcinoma

China
Eastern Hepatobiliary Surgery Hospital

Completed

Clinical Research of Licartin Combined With TACE in the Treatment of Unresectable Hepatocellular Carcinoma

Unresectable Hepatocellular Carcinoma
Eastern Hepatobiliary Surgery Hospital

Completed

Efficacy of Sequential TACE and PVE on the Resectability of Hepatitis B Related HCC (TACEPVE)

Hepatocellular Carcinoma

China
Eastern Hepatobiliary Surgery Hospital

Unknown

Surgical Resection Versus Percutaneous Local Ablative Therapy for Hepatocellular Carcinoma

Hepatocellular Carcinoma With CSPH

China
Eastern Hepatobiliary Surgery Hospital

Completed

Radioembolization With Yittrium-90 for Intermediate and Advanced Hepatocellular Carcinoma

Hepatocellular Carcinoma | Radioembolization

China
Eastern Hepatobiliary Surgery Hospital

Completed

Laser Ablation for Intermediate and Advanced Hepatocellular Carcinoma With Portal Vein Tumor Thrombus

Hepatocellular Carcinoma | Portal Vein Tumor Thrombus | Laser Ablation

China
Eastern Hepatobiliary Surgery Hospital

Completed

Rg3 in Combination With TACE in Hepatocellular Carcinoma Patients With High Expression of Notch1

Hepatocellular Carcinoma | TACE | Notch1 | Rg3

China
Eastern Hepatobiliary Surgery Hospital

Completed

Targeted Internal Radiation Therapy in Advanced HCC Patients.

Advanced Hepatocellular Carcinoma | Internal Radiation

China
Eastern Hepatobiliary Surgery Hospital

Completed

Intraoperative Chemotherapy Against Hepatocellular Carcinoma Recurrence

Hepatocellular Carcinoma

China
Eastern Hepatobiliary Surgery Hospital

Completed

Postoperative Adjuvant TACE Treatment in CK18 Positive Patients

Hepatocellular Carcinoma. | Postoperative Adjuvant TACE

China
Eastern Hepatobiliary Surgery Hospital

Completed

Ulinastatin Preventing Postoperative Hepatic Failure in Hepatocellular Carcinoma (HCC)

Hepatocellular Carcinoma

China
Eastern Hepatobiliary Surgery Hospital

Completed

Adjuvant Anti-Recurrence Treatment With Rapamycin on Early-stage HCC

Hepatocellular Carcinoma | Rapamycin

China
Eastern Hepatobiliary Surgery Hospital

Unknown

Transarterial Chemoembolization (TACE) Plus Sorafenib Versus TACE for Advanced Hepatocellular Carcinoma (TACE)

Advanced Hepatocellular Carcinoma

China
Eastern Hepatobiliary Surgery Hospital

Recruiting

Envafolimab Combined With GEMOX in First-line Treatment of Advanced GBC

Gallbladder Cancer

China
Eastern Hepatobiliary Surgery Hospital

Not yet recruiting

A Prospective Cohort Study on the Prediction of PHLF by Comparing the Prediction Model Based on VEGFA and PEDF With Indocyanine Green Clearance Test

Liver Failure After Operative Procedure
Eastern Hepatobiliary Surgery Hospital

Not yet recruiting

Neoadjuvant Therapy for Resectable Intrahepatic Cholangiocarcinoma With High Predict Risk of Lymph Node Metastasis

Intrahepatic Cholangiocarcinoma Recurrent
Eastern Hepatobiliary Surgery Hospital

Unknown

Portal Vein Embolization Using Coils Plus TAGM vs Multiple Coils for Patients With Perihilar Cholangiocarcinoma or Hepatocellular Carcinoma

Hepatocellular Carcinoma | Cholangiocarcinoma, Perihilar | Portal Vein Occlusion | Liver; Hypertrophy, Acute

China
Eastern Hepatobiliary Surgery Hospital

Unknown

Apapitatin Combined With SOX for Palliative Adjuvant Chemotherapy in Patients With Advanced Gallbladder Carcinoma

Gallbladder Carcinoma

China
Eastern Hepatobiliary Surgery Hospital

Unknown

Effect of Intraoperative Controlled Release 5-Fluorouracil Therapy on Recurrence in Hepatocellular Carcinoma Patients

Recurrence | Hepatocellular Carcinoma

China
Eastern Hepatobiliary Surgery Hospital

Completed

Standard Treatments of Very-early Stage Hepatocellular Carcinoma

Hepatocellular Carcinoma | Very-early Stage

China
Eastern Hepatobiliary Surgery Hospital

Completed

Comparison of Treatment of Recurrent HCC With Repeat Hepatectomy,and TACE With AFP Conversion (HCCTACEAFP)

Recurrent Hepatocellular Carcinoma

China
Eastern Hepatobiliary Surgery Hospital

Completed

Treatment of Portal Vein Tumor Thrombus After Hepatocellular Carcinoma Resection

Hepatocellular Carcinoma

China
Eastern Hepatobiliary Surgery Hospital

Completed

Pringle's Maneuver Versus Selective Hepatic Vascular Exclusion in Hepatectomy (SHVE)

Hepatocellular Carcinoma

China
Eastern Hepatobiliary Surgery Hospital

Completed

Hepatectomy Versus Radiofrequency Ablation for Hepatocellular Carcinoma Adjacent to Major Blood Vessels

Hepatocellular Carcinoma

China
Eastern Hepatobiliary Surgery Hospital

Completed

Transarterial Chemoembolization (TACE) Therapy of Hepatocellular Carcinoma (HCC) With Blocking Tumor Blood Temporarily and Enhancing Perfusion

Hepatocellular Carcinoma

China
Eastern Hepatobiliary Surgery Hospital

Unknown

Effect of S-Adenosyl Methionine Treatment on Recurrence After Curative Resection of Hepatocellular Carcinoma

Hepatocellular Carcinoma

China
Eastern Hepatobiliary Surgery Hospital

Completed

A Prospective Randomized Trial Comparing Partial Hepatectomy and TACE Plus PEI for Small Hepatocellular Carcinoma

Hepatocellular Carcinoma

China
Eastern Hepatobiliary Surgery Hospital

Unknown

Treatment for Patients With Multiple Hepatocellular Carcinomas Based on the NDR Scoring System

Hepatocellular Carcinoma

China
Eastern Hepatobiliary Surgery Hospital

Unknown

Prognosis of Resection and Radiotherapy in the Treatment of Intrahepatic Cholangiocarcinoma Patients

Intrahepatic Cholangiocarcinoma

China
Eastern Hepatobiliary Surgery Hospital

Completed

Preoperative Pain Control in Liver Surgery Patients

Pain, Postoperative | Hepatocellular Carcinoma

China
Eastern Hepatobiliary Surgery Hospital

Unknown

The Influence of Resection Margin on the Recurrence of Early-stage Hepatocellular Carcinoma

Hepatocellular Carcinoma

China
Eastern Hepatobiliary Surgery Hospital

Unknown

Remote Ischemia Precondition (RIPC) for Hepatic Protection in Patients Undergoing Hepatectomy

Liver Neoplasms

China
Eastern Hepatobiliary Surgery Hospital

Not yet recruiting

A Study of Danning Tablet in Patients With Polypoid Lesions of Gallbladder (PLG001)

Polyps Gallbladder

China
Eastern Hepatobiliary Surgery Hospital

Not yet recruiting

Anti-angiogenic Targeted Drugs Plus Rg3 to Improve the Efficacy of TACE for Unresectable Hepatocellular Carcinoma

Hepatocellular Carcinoma

China
Eastern Hepatobiliary Surgery Hospital

Not yet recruiting

A Trial of Adjuvant Therapy After Hepatocarcinoma Resection Based on Folate Receptor-positive Circulating Tumor Cells

Hepatocellular Carcinoma

China
Eastern Hepatobiliary Surgery Hospital

Recruiting

Prospective Surveillance for Very Early Hepatocellular Carcinoma (PRECAR)

Carcinoma, Hepatocellular

China
Eastern Hepatobiliary Surgery Hospital

Completed

Relationship Between Circulating Tumor Stem Cells and the Clinical Pathology

Hepatocellular Carcinoma | Cancer Stem Cells | Postoperative Recurrence and Metastasis

China
Eastern Hepatobiliary Surgery Hospital

Unknown

Conventional or Unconventional Lymph Node Dissection During Resection of Intrahepatic Cholangiocarcinoma

Intrahepatic Cholangiocarcinoma

China
Eastern Hepatobiliary Surgery Hospital

Completed

A Trial of Licartin for Preventing Tumor Recurrence After Liver Resection

Hepatocellular Carcinoma

China
Eastern Hepatobiliary Surgery Hospital

Completed

The Role of Low Molecular Weight Heparins in Hepatocellular Carcinoma

Hepatocellular Carcinoma

China
Eastern Hepatobiliary Surgery Hospital

Completed

Comprehensive Treatment for Different Types of Tumor Thrombi in the Portal Vein for Hepatocellular Carcinoma Patients

Hepatocellular Carcinoma | Portal Vein Tumor Thrombus

China
Eastern Hepatobiliary Surgery Hospital

Completed

A Trial of Complete Versus Selective HepaticVascular Clamping in Hepatectomy

Hepatocellular Carcinoma

China
Eastern Hepatobiliary Surgery Hospital

Completed

Efficacy and Significance of Antiviral Therapy for Unresectable Hepatitis B Virus-related Primary Liver Cancer

Primary Liver Cancer

China
Eastern Hepatobiliary Surgery Hospital

Completed

Research on Surgery and Micro-Invasive Treatment in Recurrent Primary Liver Cancer

Hepatocellular Carcinoma

China
Eastern Hepatobiliary Surgery Hospital

Completed

The Methylation Phenotype Screening and Determination Mode Study of Liver Cancer Prognosis Related Gene

Hepatocellular Carcinoma; | Radical Hepatic Resection;

China
Eastern Hepatobiliary Surgery Hospital

Unknown

Anti-recurrence Treatment of Postresection on HCC Patients With MVI Presence and Over-expression of ASPH

Hepatocellular Carcinoma

China

Clinical Trials Sponsored by Eastern Hepatobiliary Surgery Hospital

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Zambia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations